Keurig Dr Pepper Recalls McCafé Decaf K-Cups Due to Caffeine
Keurig Dr Pepper initiated a voluntary recall of over 80,000 McCafé Premium Roast Decaf Coffee K-Cup Pods on December 6, 2025, after discovering they might contain caffeinated coffee despite being labeled decaf. The U.S. Food and Drug Administration (FDA) classified this as a Class II recall on January 23, 2026, indicating that consumption could lead to temporary or medically reversible adverse health consequences, particularly for individuals sensitive to caffeine. Consumers are advised to discard the affected products or return them for a refund or replacement.
Timeline
Want updates on this thread?
Track this storyTimeline of developments
January 2026 — 7 developments
The recall, initiated by Keurig Dr Pepper in December 2025, affects approximately 960 cartons, total…
The recall, initiated by Keurig Dr Pepper in December 2025, affects approximately 960 cartons, totaling over 80,000 individual McCafé Premium Roast Decaf K-Cup Pods, which were sold exclusively through Amazon.
Further news reports continued to disseminate information about the recall, highlighting potential h…
Further news reports continued to disseminate information about the recall, highlighting potential health risks for caffeine-sensitive individuals, pregnant or breastfeeding people, children, and those with certain medical conditions.
The recalled McCafé Premium Roast Decaf K-Cup Pods were sold in 84-pod cartons in California, Indiana, and Nevada.
The recalled McCafé Premium Roast Decaf K-Cup Pods were sold in 84-pod cartons in California, Indiana, and Nevada. Consumers can identify the recalled cartons by specific markings.
Keurig Dr Pepper advised consumers who purchased the affected K-Cups to either discard them or return them to the place of purchase for a full refund or replacement.
Keurig Dr Pepper advised consumers who purchased the affected K-Cups to either discard them or return them to the place of purchase for a full refund or replacement.
News outlets began widely reporting on the voluntary recall and the FDA's classification, bringing the issue to public attention.
News outlets began widely reporting on the voluntary recall and the FDA's classification, bringing the issue to public attention.
The FDA's Class II classification indicated that consumption of the mislabeled product "may cause temporary or medically reversible adverse health consequences.
The FDA's Class II classification indicated that consumption of the mislabeled product "may cause temporary or medically reversible adverse health consequences."
The U.S. Food and Drug Administration (FDA) officially classified the recall as a Class II recall.
The U.S. Food and Drug Administration (FDA) officially classified the recall as a Class II recall.
December 2025 — 1 developments
The recall specifically involved approximately 960 cartons, each containing 84 pods, of the mislabeled decaf coffee.
The recall specifically involved approximately 960 cartons, each containing 84 pods, of the mislabeled decaf coffee.